Significant event audit

European DataWarehouse Presents 2nd Annual Data Quality Awards

Retrieved on: 
Thursday, September 28, 2023
Professional Services, Data Management, Data Analytics, Technology, Legal, Finance, Banking, Risk assessment, Research, Gesellschaft mit beschränkter Haftung, Congress, ABS, Germany, Data quality, Significant event audit, Significance, ECB, UniCredit, European DataWarehouse, Data warehouse, EDW, Cryptocurrency, European

European DataWarehouse (EDW) presented its second annual Data Quality Awards today at the 2023 TSI Congress in Berlin.

Key Points: 
  • European DataWarehouse (EDW) presented its second annual Data Quality Awards today at the 2023 TSI Congress in Berlin.
  • This year EDW presented two awards; one for Best Data Quality – Deal of the Year (2022-2023), awarded to UniCredit Bank AG for their deal, Rosenkavalier 2008 GmbH and one for Best ESG Data Quality – Deal of the Year (2022-2023), which was awarded to Arval Service Lease for their deal, FCT Pulse France 2022.
  • “We are extremely proud to have won this year’s “Best Data Quality – Deal of the Year” award from European DataWarehouse (EDW).
  • EDW identified a need to introduce data quality scoring on a deal level to easily communicate data quality and monitor its improvements as early as 2016.

EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results

Retrieved on: 
Wednesday, May 3, 2023
Workforce, Rituximab, Financial Oversight and Management Board for Puerto Rico v. Aurelius Investment, LLC, Ruxolitinib, Vincristine, AACR, MorphoSys, Doctor of Philosophy, Significant event audit, JAK, DLBCL, Conference call, Lenalidomide, American Association for Cancer Research, Cyclophosphamide, FSE, Incyte, Sale, ASCO, BET, Prednisone, American Society of Clinical Oncology, Patient, Doxorubicin, Annual general meeting, Webcast, Society, Conference, Safety, Security (finance), Nursing, Beauty salon, Video game, Pharmaceutical industry, Tafasitamab

Enrollment of Phase 3 MANIFEST-2 study of pelabresib in first-line myelofibrosis is complete, with topline data expected by the end of 2023

Key Points: 
  • Enrollment of Phase 3 MANIFEST-2 study of pelabresib in first-line myelofibrosis is complete, with topline data expected by the end of 2023
    € 791.5 million in cash and other financial assets as of March 31, 2023
    Conference call and webcast (in English) tomorrow, May 04, 2023, at 2:00pm CEST (1:00pm BST/8:00am EDT)
    MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2023.
  • Minjuvi royalty revenue of € 0.7 million for sales outside of the U.S. in the first quarter 2023 (Q1 2022: € 0.7 million).
  • On March 14, 2023, MorphoSys announced that Lucinda Crabtree, Ph.D., will join the company as its Chief Financial Officer and member of the Management Board in the third quarter of 2023 at the latest.
  • Total revenues for the first quarter 2023 were € 62.3 million compared to € 41.5 million for the same period in 2022.

MorphoSys AG Reports First Quarter 2023 Financial Results

Retrieved on: 
Wednesday, May 3, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Workforce, Rituximab, Financial Oversight and Management Board for Puerto Rico v. Aurelius Investment, LLC, Ruxolitinib, Vincristine, AACR, MorphoSys, Doctor of Philosophy, Significant event audit, JAK, DLBCL, Lenalidomide, American Association for Cancer Research, Cyclophosphamide, FSE, Incyte, Sale, ASCO, BET, Prednisone, American Society of Clinical Oncology, Patient, Doxorubicin, Annual general meeting, Society, Safety, Beauty salon, Nursing, Video game, Pharmaceutical industry, Tafasitamab

MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2023.

Key Points: 
  • MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2023.
  • Minjuvi royalty revenue of € 0.7 million for sales outside of the U.S. in the first quarter 2023 (Q1 2022: € 0.7 million).
  • On March 14, 2023, MorphoSys announced that Lucinda Crabtree, Ph.D., will join the company as its Chief Financial Officer and member of the Management Board in the third quarter of 2023 at the latest.
  • Total revenues for the first quarter 2023 were € 62.3 million compared to € 41.5 million for the same period in 2022.

EQS-News: MorphoSys AG Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, March 16, 2023
Constellation, Progression-free survival, Cancer, Research, Conference, FSE, Workforce, Lenalidomide, DLBCL, Webcast, Significant event audit, Lymphoma, Saskatchewan River Sturgeon Management Board, Tafasitamab, Patient, ASH, JAK, Safety, Conference call, Doctor of Philosophy, Cryptocurrency, Video game, Pharmaceutical industry, Ruxolitinib, Novartis, MorphoSys

MorphoSys presented at ASH 2022 results from analyses of the ongoing MANIFEST study in patients with myelofibrosis.

Key Points: 
  • MorphoSys presented at ASH 2022 results from analyses of the ongoing MANIFEST study in patients with myelofibrosis.
  • Minjuvi royalty revenue of € 0.7 million for sales outside of the U.S. in the fourth quarter  2022 and € 3.0 million for the full year of 2022.
  • Total revenues for the fourth quarter 2022 were € 81.6 million compared to € 52.9 million for the same period in 2021.
  • This increase resulted mainly from higher revenues from the global licensing agreement with Novartis executed in the fourth quarter 2022.

MorphoSys AG Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, March 15, 2023
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Constellation, Progression-free survival, Cancer, FSE, Workforce, Lenalidomide, DLBCL, Significant event audit, Lymphoma, Saskatchewan River Sturgeon Management Board, Tafasitamab, Patient, ASH, JAK, Safety, Doctor of Philosophy, Video game, Pharmaceutical industry, Ruxolitinib, Novartis, MorphoSys

MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the fourth quarter and the full year 2022.

Key Points: 
  • MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the fourth quarter and the full year 2022.
  • MorphoSys presented at ASH 2022 results from analyses of the ongoing MANIFEST study in patients with myelofibrosis.
  • Total revenues for the fourth quarter 2022 were € 81.6 million compared to € 52.9 million for the same period in 2021.
  • This increase resulted mainly from higher revenues from the global licensing agreement with Novartis executed in the fourth quarter 2022.

Imperial Reports Third Quarter 2022 Financial Results

Retrieved on: 
Wednesday, November 9, 2022
GLOBE, Liquidity, London Bullion Market Association, Mining, Gold, International Financial Reporting Standards, Copper, Imperial Metals, Capital, African Metals Corporation, Net, News, The Lady in Red (Chris de Burgh song), International, Company, London Metal Exchange, Transport, CDN, Significant event audit, Capital expenditure, TSX, COVID-19, Income, Video game, Aquaculture, Silver

Total revenue increased to $41.7 million in the September 2022 quarter compared to $37.1 million in the 2021 comparative quarter, an increase of $4.6 million.

Key Points: 
  • Total revenue increased to $41.7 million in the September 2022 quarter compared to $37.1 million in the 2021 comparative quarter, an increase of $4.6 million.
  • The London Metals Exchange cash settlement copper price per pound averaged US$3.51 in the September 2022 quarter compared to US$4.25 in the 2021 comparative quarter.
  • In CDN Dollar terms the average copper price in the September 2022 quarter was CDN$4.59 per pound compared to CDN$5.36 per pound in the 2021 comparative quarter, and the average gold price in the September 2022 quarter was CDN$2,258 per ounce compared to CDN$2,254 per ounce in the 2021 comparative quarter.
  • Gold production for the third quarter of 2022 was lower than the second quarter of 2022 due to lower recovery and lower throughput.

Imperial Reports Second Quarter 2022 Financial Results

Retrieved on: 
Monday, August 8, 2022
Liquidity, African Metals Corporation, Imperial Metals, Travel, International Financial Reporting Standards, Income, Metal, GLOBE, Capital, London Metal Exchange, TSX, Capital expenditure, London Bullion Market Association, Net, Significant event audit, COVID-19, Company, International, Copper, Transport, The Lady in Red (Chris de Burgh song), News, Gold, CDN, Lithium, Fossil fuel, Animal, Silver

Total revenue increased to $36.4 million in the June 2022 quarter compared to $34.2 million in the 2021 comparative quarter, an increase of $2.2 million.

Key Points: 
  • Total revenue increased to $36.4 million in the June 2022 quarter compared to $34.2 million in the 2021 comparative quarter, an increase of $2.2 million.
  • The London Metals Exchange cash settlement copper price per pound averaged US$4.32 in the June 2022 quarter compared to US$4.40 in the 2021 comparative quarter.
  • London Bullion Market Association, London gold price per troy ounce averaged US$1,873 in the June 2022 quarter compared to US$1,816 in the 2021 comparative quarter.
  • Metal production for the second quarter of 2022 was 22.0 million pounds copper and 19,540 ounces gold, compared to 17.6 million pounds copper and 15,450 ounces gold produced in the 2021 second quarter.

Northstar Reports First Quarter 2022 Financial Results And Announces Details Of Virtual Investor Webcast

Retrieved on: 
Tuesday, May 31, 2022
Significant event audit, Economics, Engineering, URL, Company, ESG, EBITDA, PST, International, Depreciation, Shingles, Director, Webcast, Multimedia, FEED, Mission statement, SEDAR, View, Tax, Coronavirus, Risk, COVID-19, EST, Legislation, Quarter, Industry, Carbon, Forward-looking statement, Board, General counsel, Technology, Completeness, Sale, IFRS, Q&A, International Financial Reporting Standards, Empower, Alberta Innovates, Prospectus, Achievement, CEO, Online gambling, Oil, Management, Asphalt, Recycling, Borosilicate glass, Risk management, BC

The Company has scheduled a virtual investor webcast to discuss these financial results and to provide a business update to the investment community on Tuesday, May 31, 2022 at 5:30 am PST / 8:30 am EST.

Key Points: 
  • The Company has scheduled a virtual investor webcast to discuss these financial results and to provide a business update to the investment community on Tuesday, May 31, 2022 at 5:30 am PST / 8:30 am EST.
  • In parallel with the customer testing, we have added in-house and independent third-party testing to our capabilities," Mr. Mills stated.
  • and to be incorporated into the next detailed design phase for the Calgary scale-up facility ("Empower Calgary Facility")."
  • March 2022 - Validated two of its outputs, high quality liquid asphalt and aggregate, through positive third-party test results.

Imperial Reports First Quarter 2022 Financial Results

Retrieved on: 
Saturday, May 7, 2022
COVID-19, CDN, GLOBE, Metal, Company, Travel, Significant event audit, International Financial Reporting Standards, Gold, Imperial Metals, London Metal Exchange, Liquidity, International, Capital, Copper, Income, African Metals Corporation, Capital expenditure, TSX, LBMA, News, Transport, The Lady in Red (Chris de Burgh song), Net, Video game, Fossil fuel, Cryptocurrency, Mining

VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the Company) (TSX:III) reports financial results for the three months ended March 31, 2022, as summarized in this news release and discussed in detail in the Managements Discussion & Analysis.

Key Points: 
  • VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the Company) (TSX:III) reports financial results for the three months ended March 31, 2022, as summarized in this news release and discussed in detail in the Managements Discussion & Analysis.
  • Total revenue was $33.1 million in the March 2022 quarter compared to $33.1 million in the 2021 comparative quarter.
  • The London Metals Exchange cash settlement copper price per pound averaged US$4.53 in the March 2022 quarter compared to US$3.85 in the 2021 comparative quarter.
  • LBMA cash settlement gold price per troy ounce averaged US$1,874 in the March 2022 quarter compared to US$1,798 in the 2021 comparative quarter.

Northstar Announces 2021 Financial Results and Details of Virtual Investor Webcast

Retrieved on: 
Monday, April 25, 2022
Engineering, CEO, Board, Adoption, Carbon, PST, Economics, Legislation, International, Information technology, EBITDA, Significant event audit, General counsel, Policy, Depreciation, Risk, Alberta Innovates, Q&A, Quarter, RFP, Technology, View, Prospectus, Company, Director, Webcast, Tax, Forward-looking statement, FEED, IFRS, URL, International Financial Reporting Standards, Multimedia, SEDAR, Request for proposal, BBA, EST, Oil, Recycling, Animal, Management, Asphalt, Borosilicate glass, Risk management, Ethics, BC

The Company has scheduled a virtual investor webcast to discuss these financial results and to provide a business update to the investment community on Thursday, April 28, 2022 at 2:00 pm PST / 5:00 pm EST.

Key Points: 
  • The Company has scheduled a virtual investor webcast to discuss these financial results and to provide a business update to the investment community on Thursday, April 28, 2022 at 2:00 pm PST / 5:00 pm EST.
  • Mr. Aidan Mills, President & CEO of Northstar, commented, "In 2021, the Northstar team did an excellent job of laying the groundwork for Northstar's future.
  • October 2021 - Northstar announced the successful completion of commissioning runs at its Empower Pilot Facility and completed an assessment of Request for Proposal ("RFP") submissions.
  • December 2021 - Appointed Ms. Rosemary Pritchard as Chief Financial Officer and lead for the Company's human resources and information technology.